| 9:30 AM - 9:40 AM | Chair's Opening Remarks |
| 9:40 AM - 10:25 AM | Panel Discussion: Equity in immunisation and vaccines hesitancy |
| 10:40 AM - 11:25 AM | The gonorrhea vaccine programme, what do we need to know in primary care?
- Background and overview UK gonorrhea program (increasing incidence, increasing AMR, economic burden, prevention strategy)
- Disease overview (transmission, increase in asymptomatic infections, complications, AMR)
- The vaccine – what you need to know (mechanism, eligibility and risk groups)
- How primary care can help (identification and signposting, patient conversations, reducing inequalities)
- Q+A
|
| 11:40 AM - 12:25 PM | Routine seasonal vaccines: Selection and procurement - the importance of clinical differentiation and evaluating quality of evidence
- How seasonal vaccinations programs are changing and the clinical and economic impact of vaccine selection
- Clinical differentiation (key decision factors and practical scenarios)
- Evaluating quality of evidence (study design, interpreting endpoints, trusted evidence sources)
- Procurement and practice level planning (forecasting and populations demographics, decision frameworks for selection, alignment with national guidance, supply/supplier
- considerations, scheduling and co-administration strategies)
- Q+A
|
| 12:40 PM - 1:25 PM | From flu to RSV, navigating the respiratory vaccine landscape
- Epidemiology and burden of respiratory infections
- Updates on influenza vaccines, RSV prevention (infants and children, older adults) and other respiratory immunisations
- Navigating the vaccine landscape in practice
- JCVI and guidance updates
- Q+A
|
| 1:40 PM - 2:25 PM | Travel health in transition: trends shaping clinical practice
- Overview of changing global travel patterns, evolving traveller demographics, and increasing demand across primary care
- Emerging and re-emerging infectious disease risks, including mosquito-borne illnesses, outbreak-prone diseases, and climate-driven shifts
- Vaccine developments and practical application in travel health (routine and specialist vaccines)
- Supporting clinicians in practice: risk assessment, pre-travel advice, and recognising when to refer
- Q&A
|
| 2:40 PM - 3:25 PM | Beyond flu and COVID-19 (pneumococcal and shingles)
- Why this matters now (shifting burden of vaccine‑preventable diseases, missed opportunities in primary care)
- Pneumococcal disease: what primary care needs to know (inc. practical care considerations, identifying eligible patients, co-admin with other vaccine, complex cases, common
- misconceptions)
- Shingles: what primary care needs to know (inc. disease overview, epidemiology and overview national guidance, vaccination options, framing risk to patients)
- Q+A
|
| 3:40 PM - 4:25 PM | Chickenpox (Varicella) vaccine: what primary care needs to know
- Disease overview (Varicella-zoster virus and transmission)
- JCVI recommendations
- Vaccination options (Varicella vaccines and schedules, Co-administration with MMR)
- Addressing “mild disease” perceptions
- Discussing complications and community protection
- Q+A
|
| 4:25 PM - 4:35 PM | Closing remarks |
| 4:35 PM | Conference ends |
